Income Tax Disclosure [Text Block] | Note K – Income Taxes The components of income tax (benefit) expense for the each of the years ended December 31, 2022 and 2021 are as follows: Year Ended Year Ended December 31, December 31, 202 2 20 21 Federal: Current $ - $ - Deferred - - - - State: Current - - Deferred - - - - Total $ - $ - As of December 31, 2022, the Company had an aggregate net operating loss carryforward(s) to offset future taxable income of approximately $202,000. The amount and availability of any net operating loss carryforward(s) will be subject to the limitations set forth in the Internal Revenue Code. Such factors as the number of shares ultimately issued within a three-year look-back period; whether there is a deemed more than 50% change in control; the applicable long-term tax-exempt The Company's income tax (benefit) expense for the each of the years ended December 31, 2022 and 2021 are as follows: Year Ended Year Ended December 31, December 31, 2022 2021 Statutory rate applied to loss before income taxes $ (532 ) $ (789 ) Increase (decrease) in income taxes resulting from: State income taxes - - Reserve for deferred tax asset 532 789 Income tax expense $ - $ - The Company’s only temporary difference due to statutory requirements in the recognition of assets and liabilities for tax and financial reporting purposes, as of December 31, 2022 and 2021, respectively, relate solely to the Company’s net operating loss carryforward(s) and non-deductible interest expense. These differences give rise to the financial statement carrying amounts and tax bases of assets and liabilities causing either deferred tax assets or liabilities, as necessary, as of December 31, 2022 and 2021: December 31, December 31, 2022 2021 Deferred tax assets Net operating loss carryforwards $ 42,407 $ 42,666 Less valuation allowance (42,407 ) (42,666 ) Net Deferred Tax Asset $ - $ - Year Ended Year Ended December 31, December 31, 2022 2021 Net loss before taxes per financial statements $ (2,533 ) $ (3,565 ) Temporary differences 3,767 3,756 Taxable amount 1,234 191 Income tax rate 21 % 21 % Income tax benefit at statutory rate 259 40 Valuation allowance (259 ) (40 Provision for income taxes $ - $ - During the each of the years ended December 31, 2022 and 2021, the valuation allowance for the deferred tax asset changed by $219 and $(40), respectively . In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (“2017 Tax Act”). Corporate taxpayers may carryback net operating losses (NOLs) originating between 2018 and 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for 2019 and 2020. The CARES Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act. |